Accuray Incorporated (LON:0H8I)

Market Cap	171.64M
Revenue (ttm)	361.95M
Net Income (ttm)	-3.49M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,018
Average Volume	6,191
Open	2.169
Previous Close	2.155
Day's Range	2.095 - 2.169
52-Week Range	2.172 - 4.261
Beta	n/a
RSI	42.83
Earnings Date	Apr 25, 2025

About Accuray

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, a...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1990
• Employees: 987
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0H8I

Financial Performance

In 2024, Accuray's revenue was $446.55 million, a decrease of -0.24% compared to the previous year's $447.61 million. Losses were -$15.55 million, 67.5% more than in 2023.

Financial numbers in USD